The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksThruvision Grp Regulatory News (THRU)

Share Price Information for Thruvision Grp (THRU)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 17.50
Bid: 17.00
Ask: 18.00
Change: 0.00 (0.00%)
Spread: 1.00 (5.882%)
Open: 17.50
High: 17.50
Low: 17.50
Prev. Close: 17.50
THRU Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update & Return of Capital

12 Mar 2018 07:00

RNS Number : 3358H
Thruvision Group PLC
12 March 2018
 

 

 

12 March 2018

Thruvision Group plc

 

("Thruvision" or the "Group")

 

 

Trading Update & Return of Capital

 

Thruvision (AIM: THRU) the specialist provider of people-screening technology to the international security market, is pleased to provide an update on its plans to return excess cash, resulting from the sale of the Video Business to Volpi Capital LLP in October 2017, to shareholders, and on trading progress since publication of the Group's Interim Results in December 2017.

 

Return of Capital

The Board intends to return up to £8 million to shareholders through a tender offer, possibly combined with an on-market share buy-back programme. In order to effect the return, some capital restructuring of the Group is required, the first step of which is explained fully in the Circular to shareholders to be issued later today and entitled "Proposed cancellation of Share Premium Account and Capital Redemption Reserve and Notice of General Meeting".

 

Trading Update

The much more focused nature of the Group's activities following the disposal of the Video Business has driven positive progress since the publication of the Group's interim results in December 2017. The Group has already shipped a record number of its people-screening units to customers in the current financial year to date. This gives further confidence that there should be a large, international market for our people-screening security technology.

In addition, further market engagement has fully validated Thruvision's significant advantages over other types of people-screening technology. In particular:

· Thruvision provides instant, real-time video showing the size, shape and location of concealed threats at distances up to 8m;

· Thruvision has a lower cost of ownership than alternative technologies;

· Thruvision does not generate anatomical details of persons screened thereby eliminating privacy issues raised by some other technologies;

· Thruvision is effective at high-throughput levels, screening over 2,000 people per hour in recent operational trials; and

· Thruvision is a passive technology and emits no ionizing radiation.

 

Based on these unique capabilities, we have further refined our market focus on four distinct areas:

· Mass Transit - screening for suicide vests and other threats in railways, subways and airport concourses.

· Entrance - screening for all types of weapon at entrances to buildings, sports stadia and other public venues.

· Loss Prevention - screening for items stolen from warehouses or factories.

· Customs - screening for prohibited items at borders.

 

This market focus, and additional sales resource brought into the Group, has resulted in the material pick up in order intake referred to above. Recent highlights include significant orders from the Philippines for mass transit screening and from China for entrance screening, a further order from Saudi Arabia for entrance screening, and several orders from new UK-based loss prevention customers.

 

Significant progress has also been made in the US with the Transportation Security Administration ('TSA'), following the funded development of a new product for them, the Thruvision "TAC". In late February and early March, the Thruvision TAC, has been publicly demonstrated by TSA with Amtrak in Penn Station, New York, and with LA Metro in Los Angeles, with widespread media coverage. Operational feedback has been positive and David Pekoske, the TSA Administrator, described the trial of stand-off detection technology at Penn Station as "very promising". We are in the process of initiating production of this new product with our US-based partner in anticipation of TSA's final product approval over the summer.

 

Ian Lindsay, our new Finance Director has now started, and with the process of separating the Video Business effectively complete, the Group expects to head into the new financial year with a clear strategy, strong international sales momentum and net cash materially unchanged since our Interim Results in December at c£17m.

 

 

 

 

For further information please contact:

 

Thruvision Group plc +44 (0)20 3553 5888

Tom Black, Executive Chairman

Colin Evans, Managing Director

 

Investec Bank plc +44 (0)20 7597 5970

Andrew Pinder / Sebastian Lawrence / Patrick Robb

 

FTI Consulting LLP +44 (0)20 3727 1000

Matt Dixon / Harry Staight

 

 

 

 

About Thruvision

Thruvision Group plc is a specialist provider of people-screening technology that can detect weapons, explosives and contraband hidden under clothing. Developed with extensive support from the British and US Governments, Thruvision technology is operationally proven and is being used to enhance the security of transport hubs, borders, high profile buildings and public areas.

 

 

www.thruvision.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTLLFEEVFIILIT
Date   Source Headline
26th Apr 20247:00 amRNSYear-end trading update
18th Mar 20247:00 amRNSWalkTHRU completes operational test and evaluation
1st Feb 20247:00 amRNSNext generation product range & software launched
26th Jan 20247:00 amRNSSales Progress Update
22nd Jan 20242:48 pmRNSHolding(s) in Company
10th Jan 202410:39 amRNSAward of Share Options to Executive Director
28th Nov 202311:50 amRNSBlocklisting update
28th Nov 202311:48 amRNSBlocklisting update
20th Nov 20237:00 amRNSInterim Results
13th Nov 20238:51 amRNSUK retail theft to cost £7.9bn in 2023
6th Nov 20234:27 pmRNSNotice of Interim Results
27th Oct 202311:32 amRNSHolding(s) in Company
26th Oct 20232:34 pmRNSHolding(s) in Company
26th Oct 20232:23 pmRNSHolding(s) in Company
25th Oct 202312:04 pmRNSHolding(s) in Company
24th Oct 20237:00 amRNSResult of placing
23rd Oct 20234:35 pmRNSLaunch of placing
2nd Oct 20237:00 amRNSHalf year trading update
21st Sep 202311:12 amRNSResult of Annual General Meeting
22nd Aug 202311:56 amRNSAward of Share Options to Executive Directors
21st Jul 20237:00 amRNSResults for the year ended 31 March 2023
13th Jul 20235:09 pmRNSNotice of Results
7th Jun 20237:00 amRNSBlocklisting update
7th Jun 20237:00 amRNSBlocklisting update
21st Apr 20237:00 amRNSYear end trading update
3rd Feb 20237:00 amRNSSharesave option grant to Executive Director
12th Jan 202310:24 amRNSChange of Auditor
21st Dec 20227:00 amRNSDirector Share Dealing
19th Dec 20227:00 amRNSInterim Results
15th Dec 20227:00 amRNSCORRECTION - Blocklisting Update
13th Dec 20227:00 amRNSBlocklisting Update
13th Dec 20227:00 amRNSBlocklisting Update
30th Nov 20227:00 amRNSNotice of Results
9th Nov 20227:00 amRNSAward of Share Options to Executive Directors
8th Nov 20222:50 pmRNSHolding(s) in Company
26th Oct 202211:50 amRNSResult of AGM
12th Oct 20227:00 amRNSH1 Trading Update
3rd Oct 20227:00 amRNSCBP Framework Agreement and Contract Award
30th Sep 20227:00 amRNSResults for the Year ended 31 March 2022
22nd Sep 20223:00 pmRNSContract Award, Trading Update, Notice of Results
16th Jun 20227:00 amRNSAppointment of Chief Financial Officer
15th Jun 20228:31 amRNSHolding(s) in Company
8th Jun 20223:32 pmRNSBlocklisting update
8th Jun 20223:30 pmRNSBlocklisting update
6th May 202212:12 pmRNSDirector Share Dealing-correction & further trade
20th Apr 20227:00 amRNSDirector Share Dealing
4th Apr 20227:00 amRNSYear End Trading Update and Board Changes
1st Apr 20227:01 amRNSBlocklisting update
1st Apr 20227:00 amRNSBlocklisting update
9th Mar 202212:40 pmRNSDirector Share Dealing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.